ABIVAX Société Anonyme (EPA:ABVX)
64.00
+2.20 (3.56%)
Jul 31, 2025, 5:35 PM CET
Nordstrom Revenue
ABIVAX Société Anonyme had revenue of 4.01M EUR in the half year ending December 31, 2024, with 78.20% growth. This brings the company's revenue in the last twelve months to 10.59M, up 128.98% year-over-year. In the year 2024, ABIVAX Société Anonyme had annual revenue of 10.79M with 135.94% growth.
Revenue (ttm)
10.59M
Revenue Growth
+128.98%
P/S Ratio
456.64
Revenue / Employee
153.45K
Employees
69
Market Cap
4.83B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10.79M | 6.22M | 135.94% |
Dec 31, 2023 | 4.57M | 69.00K | 1.53% |
Dec 31, 2022 | 4.51M | 302.00K | 7.19% |
Dec 31, 2021 | 4.20M | 4.19M | 29,921.43% |
Dec 31, 2020 | 14.00K | 21.00K | -300.00% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
EssilorLuxottica Société anonyme | 27.24B |
Sanofi | 45.17B |
Sartorius Stedim Biotech | 2.90B |
bioMérieux | 3.98B |
Eurofins Scientific SE | 7.14B |
Ipsen | 3.57B |
Virbac | 1.40B |
emeis Société anonyme | 5.64B |
ABIVAX Société Anonyme News
- 3 days ago - Abivax Announces Closing of $747.5 Million Public Offering - GlobeNewsWire
- 6 days ago - Abivax Announces Full Exercise of Underwriters' Option to Purchase Additional ADSs, Bringing ... - GuruFocus
- 6 days ago - Abivax Announces Full Exercise of Underwriters' Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M) - GlobeNewsWire
- 7 days ago - Abivax: Positive Obefazimod Induction Data Leads To Next 44-Week Maintenance Trial Catalyst - Seeking Alpha
- 7 days ago - Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares - GlobeNewsWire
- 7 days ago - Abivax announces trading resumption of its ordinary shares on Euronext Paris - GlobeNewsWire
- 7 days ago - Abivax launches $400M ADS offering - Seeking Alpha
- 7 days ago - Abivax announces temporary trading halt of its ordinary shares on Euronext Paris - GlobeNewsWire